JYJianyuan Yin

Jianyuan Yin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jianyuan Yin has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Guangguang Du

    Department of Natural Product Chemistry, College of Pharmacy Jilin University Changchun China

    2 shared publications
  • Jihua Liu

    School of Pharmaceutical Sciences Jilin University Changchun China

    2 shared publications
  • Baohua Zheng

    Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China

    1 shared publication
  • Chunfang Zhao

    Department of Natural Product Chemistry, College of Pharmacy Jilin University Changchun China

    1 shared publication
  • Cong Geng

    Department of Clinical Laboratory The Second Affiliated Hospital of Dalian Medical University Dalian China

    1 shared publication
  • Dandan Sun

    School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China

    1 shared publication

Latest Publications

  • Identification of metabolites in plasma related to different biological activities of Panax ginseng and American ginseng

    by Jihua Liu, Qinghai Dong, Guangguang Du, Jia Wang, Yang An, Jiayin Liu, Jun Su, Hongliu Xie, Jianyuan Yin

    Rationale: Panax ginseng (PG) and American ginseng (AMG) are both medicinal plants of the Panax genus in the Acanthopanax family. Although PG and AMG have similar components of ginsenosides, there are many differences of their bioactivities. In this study, the biochemical mechanisms of different bioactivities of PG and AMG were explored by researching the differential metabolites in plasma after administration of each of PG and AMG. Methods: In order to explore the material basis of differential bioactivities, two groups of mice were administrated orally with PG and AMG, and the method of metabolomics was used to identify the differential metabolites in plasma. Then network pharmacology was used based on the differential metabolites. Afterward, the metabolite–target–pathway network of PG and AMG was constructed; thus the pathways related to different bioactivities were analyzed. Results: Through principal component analysis and orthogonal projections to latent structures discriminant analysis, there were 10 differential metabolites identified in the PG group and 8 differential metabolites identified in the AMG group. Based on network pharmacology, the differential metabolites were classified and related to differential bioactivities of PG and AMG. In the PG group, there were 6 metabolites related to aphrodisiac effect and exciting the nervous system, and 5 metabolites associated with raised blood pressure. In the AMG group, 5 metabolites were classified as having the effect of inhibiting the nervous system, and 6 metabolites were related to antihypertensive effect. Conclusions: This study explored the material basis of the differential biological activities between PG and AMG, which is significant for the research of PG and AMG use and to promote human health.


  • Different absorption and metabolism of ginsenosides after the administration of total ginsenosides and decoction of Panax ginseng

    by Jihua Liu, Ting Li, Jia Wang, Chunfang Zhao, Cong Geng, Qin Meng, Guangguang Du, Jianyuan Yin

    Rationale: Panax ginseng C.A. Meyer (PG), which contains polysaccharides and ginsenosides as the major bioactive components, has been used to promote health and treat diseases for thousands of years in China. Total ginsenosides were extracted from a decoction of Panax ginseng (GD), which included both ginsenosides and polysaccharides, and dissolved in water to obtain a total ginsenosides aqueous solution (TGAS). To study their absorption and metabolism, the pharmacokinetics (PK) and metabolites of ginsenosides in vivo were investigated after the administration of GD and TGAS. Methods: Rat and mice plasma samples were collected after the administration of GD and TGAS. Ultra‐performance liquid chromatography coupled with time‐of‐flight mass spectrometry was used with the UNIFI platform to identify metabolites in the plasma sample. The pharmacokinetic parameters were calculated using a noncompartmental method in the Drug and Statistics software package. Results: Thirty ginsenoside metabolites were identified in mice plasma, of which only seven were found in the rat plasma after the administration of GD. The PK of ginsenosides Rb 1 , Rc, and Rd were also determined after the oral administration of GD and TGAS and showed significant differences in the pharmacokinetic parameters. Conclusions: There was no difference in the biotransformation pathways after the oral administration of GD and TGAS, indicating that there was no influence of polysaccharides on the biotransformation of ginsenosides in vivo . However, the pharmacokinetic parameters were different after the administration of GD and TGAS, possibly because of the polysaccharides in GD. This study should be of significance in exploring the basis of PG bioactivities and lays the foundation for the further development of new drugs using PG.


  • The effects of ginsenosides to amyloid fibril formation by RCMκ-casein

    by Jihua Liu, Fanbo Chen, Jianyuan Yin, Fengquan Bu, Baohua Zheng, Miao Yang, Yunhua Wang, Dandan Sun, Qin Meng